Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Cass

Showing results (221-230 of 289) with videos related to

Pageof 29
Sort By:
BMC Nephrology|June 28, 2015
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsAndrea K Viecelli, Elaine Pascoe, Kevan R Polkinghorne, et al.
International Journal for Equity in Health|June 25, 2017
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseBlake Angell, Tracey-Lea Laba, Tom Lung, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
BMC Medical Informatics and Decision Making|March 8, 2024
Developing an integrated clinical decision support system for the early identification and management of kidney disease-building cross-sectoral partnershipsGillian Gorham, Asanga Abeyaratne, Sam Heard, et al.
BMC Oral Health|February 5, 2021
Oral health of aboriginal people with kidney disease living in Central AustraliaKostas Kapellas, Jaquelyne T Hughes, Alan Cass, et al.
Australian Health Review : a Publication of the Australian Hospital Association|April 19, 2019
Incident haemodialysis and outcomes in the Top End of AustraliaJaquelyne T Hughes, Sandawana W Majoni, Federica Barzi, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Plos One|July 16, 2019
The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative studyEdward Zimbudzi, Clement Lo, Tracy Robinson, et al.
Nephrology (Carlton, Vic.)|May 16, 2017
Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up StudyElizabeth Lm Barr, Federica Barzi, Jaquelyne T Hughes, et al.
Nephrology (Carlton, Vic.)|November 11, 2014
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility StudyMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Pageof 29

Showing results (221-230 of 289) with videos related to

Sort By:
Pageof 29
BMC Nephrology|June 28, 2015
The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsAndrea K Viecelli, Elaine Pascoe, Kevan R Polkinghorne, et al.
International Journal for Equity in Health|June 25, 2017
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular diseaseBlake Angell, Tracey-Lea Laba, Tom Lung, et al.
Diabetes Care|March 13, 2020
Incidence and Associations of Chronic Kidney Disease in Community Participants With Diabetes: A 5-Year Prospective Analysis of the EXTEND45 StudyLouisa Sukkar, Amy Kang, Carinna Hockham, et al.
BMC Medical Informatics and Decision Making|March 8, 2024
Developing an integrated clinical decision support system for the early identification and management of kidney disease-building cross-sectoral partnershipsGillian Gorham, Asanga Abeyaratne, Sam Heard, et al.
BMC Oral Health|February 5, 2021
Oral health of aboriginal people with kidney disease living in Central AustraliaKostas Kapellas, Jaquelyne T Hughes, Alan Cass, et al.
Australian Health Review : a Publication of the Australian Hospital Association|April 19, 2019
Incident haemodialysis and outcomes in the Top End of AustraliaJaquelyne T Hughes, Sandawana W Majoni, Federica Barzi, et al.
Kidney International|January 11, 2013
Intensive glucose control improves kidney outcomes in patients with type 2 diabetesVlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, et al.
Plos One|July 16, 2019
The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative studyEdward Zimbudzi, Clement Lo, Tracy Robinson, et al.
Nephrology (Carlton, Vic.)|May 16, 2017
Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up StudyElizabeth Lm Barr, Federica Barzi, Jaquelyne T Hughes, et al.
Nephrology (Carlton, Vic.)|November 11, 2014
The rationale and design of the Beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) Feasibility StudyMatthew A Roberts, Helen L Pilmore, Francesco L Ierino, et al.
Pageof 29